|
|
| Research article summary (published 30 Jan 1996): |
Surgical resection of brain metastases from renal cell carcinoma in 50 patients.
Full Abstract
OBJECTIVES: Metastases are frequently diagnosed among patients with renal cell carcinoma (RCC). Of 709 patients with brain metastases (BMET) who were operated on at our institution between 1974 and 1993, 50 (7%) were of renal origin. METHODS: Medical records were reviewed retrospectively. Survival time was calculated by the Kaplan-Meier method and Cox proportional hazards model. RESULTS: There were 38 men and 12 women. The median age was 60 years. The primary RCC was resected in 47 patients. Forty patients had a metachronous diagnosis of RCC and BMET. Median interval between the diagnosis of RCC and BMET was 17 months. In all 50 patients overall median survival (MS) from diagnosis of primary RCC was 31.4 months and from craniotomy was 12.6 months. Postoperative mortality was 10% (5 patients). In patients with primary RCC in the left kidney (n=25) versus right kidney (n=25) median survival from craniotomy was longer; 21.3 versus 7.4 months (P<0.014). Twenty-three patients (46%) had intratumoral hemorrhage. Eight patients had cerebellar metastasis (MS, 3.0 months) and 9 had multiple metastases resected (MS, 7.6 months). Thirty-eight patients had both brain and pulmonary metastases, and 16 of them had pulmonary resection (MS, 18.6 versus 8.0 months; P<0.03). Twenty-two patients received whole-brain radiation therapy (WBRT) after craniotomy and 18 did not receive WBRT (MS, 13.3 versus 14.5 months; P<0.62). The 1-year, 2-year, 3-year, and 5-year survival was 51%, 24%, 22%, and 8.5% respectively. CONCLUSIONS: Only the resection of lung metastasis, supratentorial location of BMET, left-sided localization of primary RCC, and lack of neurologic deficit before craniotomy were statistically significant prognostic factors in Cox regression analysis. In the absence of effective systemic treatment, we suggest that patients with BMET from RCC be considered for operative resection for treatment and palliation.
Author information
Author/s: Wronski, M (M); Arbit, E (E); Russo, P (P); Galicich, J H (JH);
Affiliation: Neurosurgery Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Journal and publication information
Publication Type: Journal Article
Journal: Urology (Urology), published in UNITED STATES. (Language: eng)
Reference: 1996-Feb; vol 47 (issue 2) : pp 187-93
Dates: Created 1996/05/17; Completed 1996/05/17; Revised 2004/11/17;
PMID: 8607231, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Single brain metastases from kidney tumors. Clinico-pathologic considerations on a series of 29 cases.
29 Dec 1992 - Radiation therapy in the treatment of metastatic renal-cell carcinoma.
30 Dec 1989 - MR imaging of hemorrhagic intracranial neoplasms.
30 Dec 1988 - Palliative radiotherapy for brain metastases in renal carcinoma.
30 Oct 1988 - Surgical treatment of metastatic renal cell carcinoma.
30 Aug 1990 - Radiosurgery for solitary brain metastases using the cobalt-60 gamma unit: methods and results in 24 patients.
30 May 1991 - [Treatment of metastatic brain tumor from renal cell carcinoma]
29 Sep 1990 - [Usefulness and limitation of immunotherapy of metastatic renal cell carcinoma with autologous lymphokine-activated killer cells and interleukin 2]
27 Feb 1991 - Low incidence of asymptomatic brain metastases in patients with renal cell carcinoma.
29 Sep 1990 - Resection of brain metastases from non-small-cell lung carcinoma. Results of therapy. Memorial Sloan-Kettering Cancer Center Thoracic Surgical Staff.
28 Feb 1992
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.